Company Data
Cingulate Inc.
Ticker
CING
Current Price
$3.92 -1.75%
Market Cap
$16.6M
Price Target
Refer to Report
Volume
90.5K
52wk Range
$1.8001 - $20.83
Overview
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.